The Bonus That Followed the Referrals
A 40-provider orthopedic group pays its six highest-revenue physicians a quarterly 'productivity bonus.' The formula is 30% of the group's net collections on imaging and physical therapy services ordered by that physician during the quarter, regardless of who performed or supervised the service. The group owns its MRI and PT suite. Last quarter one surgeon received $61,000 under this formula; his professional clinical collections were only $340,000. The compliance officer flags the arrangement after a new CFO asks whether it is 'Stark-clean.' The group's attorney says the bonus is fine because the physicians are employees and 'employees can be paid productivity bonuses.' No fair market value review has ever been done on the formula.
1. Identify the legal exposure and explain why the attorney's statement is incomplete.
Read the worked answer
The attorney's statement is half-true and dangerously incomplete. Under the Stark Law's bona fide employment exception (42 C.F.R. §411.357(c)), productivity bonuses to employed physicians are permitted only if the compensation does not directly or indirectly take into account the volume or value of referrals of designated health services (DHS) - unless a specific exception applies. Here the bonus is calculated on net collections from DHS the physician ordered (imaging and PT are DHS), which is the paradigm of volume/value-based compensation. The 'in-office ancillary services' exception may protect the billing of the MRI/PT, but it does not sanitize a compensation formula that ties pay to DHS referrals.
Separately, the Anti-Kickback Statute is an intent-based statute: paying a physician a percentage of profits on services he orders creates a remuneration-for-referrals risk, and the AKS safe harbor for employees (42 C.F.R. §1001.952(i)) protects bona fide employment compensation but does not bless a formula that rewards referrals. The lack of an FMV review compounds the exposure because the group cannot show the bonus reflects fair market value for services rendered rather than a disguised kickback. Bottom line: the arrangement should be suspended pending restructuring to a compliant productivity model (e.g., based on the physician's own personally performed professional services, or a DHS-neutral metric).
2. Draft the immediate corrective steps the compliance officer should recommend, and explain the sequencing.
Read the worked answer
Sequence matters - stop the bleeding, then remediate, then document.
- Freeze and quantify (immediate). Suspend the bonus formula prospectively; do not claw back or 'fix' retroactively without counsel. Pull 3–4 years of bonus payments and calculate the DHS-attributable portion to size potential overpayment exposure.
- Legal analysis (days). Obtain a written Stark/AKS opinion on both the existing formula and a redesigned one. Confirm whether any exception (e.g., a compliant productivity bonus under the employment exception, or an FMV-based arrangement) can be structured.
- Redesign (weeks). Replace the DHS-collections formula with compensation tied to the physician's own personally performed professional services, or a blend that excludes DHS ordered. Obtain an independent FMV opinion and document the rationale.
- Disclosure decision (after quantification). With counsel, evaluate whether an overpayment exists that triggers the 60-day repayment rule under the False Claims Act (42 U.S.C. §1320a-7k(d)) and whether self-disclosure (OIG Self-Disclosure Protocol or CMS SDRP) is warranted. Do not let the 60-day clock run silently.
- Governance fix. Add a mandatory compliance review and FMV validation to the physician-compensation approval workflow; document the board/committee approval of the new formula.
The key judgment: the compliance officer must not accept 'we're employees, so it's fine' as a legal conclusion - get independent legal and valuation input, and preserve the analysis.